| Literature DB >> 30409559 |
Rahul Shinde1, Tracy L McGaha2.
Abstract
The aryl hydrocarbon receptor (AhR) is a cytoplasmic receptor and transcription factor activated through cognate ligand binding. It is an important factor in immunity and tissue homeostasis, and structurally diverse compounds from the environment, diet, microbiome, and host metabolism can induce AhR activity. Emerging evidence suggests that AhR is a key sensor allowing immune cells to adapt to environmental conditions and changes in AhR activity have been associated with autoimmune disorders and cancer. Furthermore, AhR agonists or antagonists can impact immune disease outcomes identifying AhR as a potentially actionable target for immunotherapy. In this review, we describe known ligands stimulating AhR activity, downstream proinflammatory and suppressive mechanisms potentiated by AhR, and how this understanding is being applied to immunopathology to help control disease outcomes.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30409559 PMCID: PMC7182078 DOI: 10.1016/j.it.2018.10.010
Source DB: PubMed Journal: Trends Immunol ISSN: 1471-4906 Impact factor: 16.687